II.1)
Scope of the procurement
Provision of Bypassing agents for the treatment of Haemophilia with inhibitors
33141530
-
Blood coagulants
Supplies
II.1.4)
Short description
Provision of Bypassing agents for the treatment of Haemophilia with inhibitors for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2018
II.1.5)
Estimated total value
Value excluding VAT: 2000000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2.2)
Additional CPV code(s)
33141510
-
Blood products
33141630
-
Blood plasma filters
33620000
-
Medicinal products for the blood, blood-forming organs and the cardiovascular system
33621200
-
Antihaemorrhagics
II.2.3)
Place of performance
Main site or place of performance:
James Street
II.2.4)
Description of the procurement
Provision of Bypassing agents for the treatment of Haemophilia with inhibitors for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2018
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 2000000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
24
This contract is subject to renewal:
no
II.2.9)
Information about the limits on the number of candidates to be invited
Envisaged number of candidates:
5
II.2.10)
Information about variants
Variants will be accepted:
yes
II.2.11)
Information about options
Options:
no
II.2.12)
Information about electronic catalogues
Tenders must be presented in the form of electronic catalogues or include an electronic catalogue
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no